330 related articles for article (PubMed ID: 37540398)
1. The Potential of Psychedelics for the Treatment of Episodic Migraine.
Schindler EAD
Curr Pain Headache Rep; 2023 Sep; 27(9):489-495. PubMed ID: 37540398
[TBL] [Abstract][Full Text] [Related]
2. Psychedelics as preventive treatment in headache and chronic pain disorders.
Schindler EAD
Neuropharmacology; 2022 Sep; 215():109166. PubMed ID: 35718005
[TBL] [Abstract][Full Text] [Related]
3. Psychedelics in the Treatment of Headache and Chronic Pain Disorders.
Schindler EAD
Curr Top Behav Neurosci; 2022; 56():261-285. PubMed ID: 35546382
[TBL] [Abstract][Full Text] [Related]
4. Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.
Schindler EAD; Sewell RA; Gottschalk CH; Luddy C; Flynn LT; Lindsey H; Pittman BP; Cozzi NV; D'Souza DC
Neurotherapeutics; 2021 Jan; 18(1):534-543. PubMed ID: 33184743
[TBL] [Abstract][Full Text] [Related]
5. Are psychedelics the answer to chronic pain: A review of current literature.
Kooijman NI; Willegers T; Reuser A; Mulleners WM; Kramers C; Vissers KCP; van der Wal SEI
Pain Pract; 2023 Apr; 23(4):447-458. PubMed ID: 36597700
[TBL] [Abstract][Full Text] [Related]
6. Psychedelic drugs for psychiatric disorders.
da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
[TBL] [Abstract][Full Text] [Related]
7. The Therapeutic Potential of Psilocybin.
Lowe H; Toyang N; Steele B; Valentine H; Grant J; Ali A; Ngwa W; Gordon L
Molecules; 2021 May; 26(10):. PubMed ID: 34063505
[TBL] [Abstract][Full Text] [Related]
8. Adapting psychedelic medicine for headache and chronic pain disorders.
Schindler EAD; Hendricks PS
Expert Rev Neurother; 2023; 23(10):867-882. PubMed ID: 37652000
[TBL] [Abstract][Full Text] [Related]
9. The psychedelic effects of cannabis: A review of the literature.
Wolinsky D; Barrett FS; Vandrey R
J Psychopharmacol; 2024 Jan; 38(1):49-55. PubMed ID: 37947321
[TBL] [Abstract][Full Text] [Related]
10. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717
[TBL] [Abstract][Full Text] [Related]
11. Psychedelics and Psychedelic-Assisted Psychotherapy.
Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM;
Am J Psychiatry; 2020 May; 177(5):391-410. PubMed ID: 32098487
[TBL] [Abstract][Full Text] [Related]
12. The varieties of psychedelic law.
Marks M
Neuropharmacology; 2023 Mar; 226():109399. PubMed ID: 36565855
[TBL] [Abstract][Full Text] [Related]
13. Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.
Schindler EAD; Sewell RA; Gottschalk CH; Luddy C; Flynn LT; Zhu Y; Lindsey H; Pittman BP; Cozzi NV; D'Souza DC
Headache; 2022 Nov; 62(10):1383-1394. PubMed ID: 36416492
[TBL] [Abstract][Full Text] [Related]
14. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.
Carhart-Harris RL; Goodwin GM
Neuropsychopharmacology; 2017 Oct; 42(11):2105-2113. PubMed ID: 28443617
[TBL] [Abstract][Full Text] [Related]
15. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
Johnson MW
Curr Top Behav Neurosci; 2022; 56():213-227. PubMed ID: 35704271
[TBL] [Abstract][Full Text] [Related]
16. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
Majić T; Schmidt TT; Gallinat J
J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
[TBL] [Abstract][Full Text] [Related]
17. Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.
Schindler EAD; Sewell RA; Gottschalk CH; Flynn LT; Zhu Y; Pittman BP; Cozzi NV; D'Souza DC
J Neurol Sci; 2024 May; 460():122993. PubMed ID: 38581739
[TBL] [Abstract][Full Text] [Related]
18. Compassionate use of psychedelics.
Greif A; Šurkala M
Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195
[TBL] [Abstract][Full Text] [Related]
19. Role of Psychedelics in Treatment-Resistant Depression.
Kamal S; Jha MK; Radhakrishnan R
Psychiatr Clin North Am; 2023 Jun; 46(2):291-305. PubMed ID: 37149346
[TBL] [Abstract][Full Text] [Related]
20. Psychedelic Psychiatry's Brave New World.
Nutt D; Erritzoe D; Carhart-Harris R
Cell; 2020 Apr; 181(1):24-28. PubMed ID: 32243793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
